Category : Pharmaceuticals & Healthcare
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany
Synopsis
GBI Research, a leading business intelligence provider, has released its latest research report, "Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany".
Browse complete Report
http://www.aarkstore.com/pharmaceuticalshealthcare/94560/glioblastoma-multiforme-therapeutics-in-majordeveloped-markets-to-2020-growth-to-hinge-on-the-success-ofpersonalized-vaccine-following-early-approval-in-germany
Summary Due to the poor prognosis under currently available treatments, therapies with high potency are in strong demand in the Glioblastoma Multiforme (GBM) market. In newly diagnosed patients, the current standard of care, comprising resection surgery, radiation therapy and chemotherapy with Mercks Temodar (temozolomide), has a maximum Overall Survival (OS) of 15 months and almost inevitable tumor recurrence. Current therapeutic options for recurrent GBM are Roches Avastin (bevacizumab), carmustine and other chemotherapy drugs used off-label. However, they only offer limited OS benefit, leaving high unmet need in this patient segment.
Table of contents 1 Table of Contents 4 1.1 List of Tables 6 1.2 List of Figures 7 2 Introduction 8 2.1 Disease Introduction 8 2.2 Classification of Brain Tumors 9 2.3 Tumor Grading 11 2.4 Subtypes of Glioblastoma Multiforme 12 2.5 Etiology 12 2.6 Pathophysiology 13
Related Reports ►
http://www.aarkstore.com/pharmaceuticalshealthcare/110859/mens-health-changing-male-attitudes-tohealth-to-improve-prognosis-and-outcomes
►
http://www.aarkstore.com/pharmaceuticalshealthcare/110732/almac-discovery-ltd-product-pipeline-review2015
►
http://www.aarkstore.com/pharmaceuticalshealthcare/110731/summit-corporation-plc-product-pipelinereview-2015
►
http://www.aarkstore.com/pharmaceuticalshealthcare/110730/valentia-biopharma-sl-product-pipelinereview-2015
►
http://www.aarkstore.com/pharmaceuticalshealthcare/110729/immunomic-therapeutics-inc-product-pipelinereview-2015
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Published: June 2014 – 112 Pages
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Price
Format
Price
$ 4995
Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953
You Can Visit http://www.aarkstore.com OR
Mail us at contact@aarkstore.com Blog :
http://www.aarkstore.com/blog/
Conference :
http://conference.aarkstore.com/
News :
http://www.aarkstore.com/news